Abstract

BackgroundThe olfactory system has a widely distributed anatomical network reaching both cortical and subcortical structures (Milardi et al., 2017). Olfactory dysfunction has been associated with schizophrenia (Moberg & Turetsky, 2003), where deficits in odour identification (Seidman et al., 1997), odor detection threshold sensitivity (Serby et al., 1990) and odour memory (Wu et al., 1993) can be seen early in the course of the disorder and persist with illness duration (Rupp, 2010). This olfactory dysfunction has been correlated with cognitive deficits, including language (Corcoran et al., 2005), verbal and non-verbal memory (Moberg et al., 2006) and tests of emotional recognition (Goudsmit et al., 2003) in schizophrenia. Neuroanatomically, areas of the temporal lobe, including the superior temporal gyrus, hippocampus and amygdala have all been implicated in the dysfunction. It is not known whether olfactory changes can be detected in the broader extended psychosis phenotype.MethodsThe current research focuses on a community-based sample of young adolescents aged 11–13 (N= 140) recruited from schools in the Dublin and Kildare areas of Ireland, These adolescents were assessed for psychotic symptoms using the psychosis section of the Schedule for Affective Disorders and Schizophrenia and also completed the Brief Smell Identification Test (BSIT), derived from the University of Pennsylvania Smell Identification Test (UPSIT),as part of a neuropsychological assessment. The BSIT is a self-administered 12-item test of olfactory functioning, containing common odours (eg lemon, chocolate, and smoke) and participants were required to choose one of four multiple-choice answers.ResultsPerformance on the BSIT was compared between participants who reported any psychotic experiences (PE) (N=71), and those who did not (N=69). We examined total score and scores for individual smell types, using ANOVA, and co-varied for age and gender.ResultsA significant group difference was found when both age and gender were co-varied for, in which the PE group performed significantly better on the BSIT (F=5.56, p= 0.02), and one of the individual twelve odours (‘‘paint- thinner’’) of the BSIT also was significantly better identified by the PE group (F=7.53, p=0.007). When examined in terms of correlations with psychotic symptoms, BSIT scores were found to significantly correlate with Grandiosity, one of the eight categories of the Adolescent Psychotic-Like Symptoms Screener (APSS) (p=0.004).DiscussionMoberg et al. (2013) report that positive symptoms of psychosis may be moderating our results, where it was hypothesized that this early olfactory hypersensitivity is due to increased vigilance of external and internal stimuli. Corcoran et al. (2005) similarly found that the presence of features associated with mania, such as grandiosity, was associated with better outcomes in smell identification tests.We hope to extend our analysis to search for neuroanatomical and neuropsychological correlates of these olfactory performance scores in young people with and without psychotic symptoms, as well as looking more in-depth at positive symptoms reported by the PE group and their possible associations with this increased hypersensitivity in olfactory identification. The current research is hoped to capture some of the earliest olfactory changes associated with psychosis vulnerability as a possible biomarker. The study employs a novel participant cohort whom are considered an extended psychosis phenotype and at this point only exhibit psychotic symptoms, but remain at an increased risk of the development of psychosis in adulthood.

Highlights

  • Schizophrenia is a disorder with a heterogeneous genetic and neurobiological background that influences early brain development

  • obstetric complications (OC) have been linked to an increased risk for schizophrenia in offspring, especially in early-onset schizophrenia (EOS)

  • Information on OC was collected from the NMBR containing information about all births in Norway, including information about maternal health before and during pregnancy, and any complications arising during pregnancy or birth

Read more

Summary

Background

Electroconvulsive therapy (ECT) is the most popular way to stimulate brain for achieving therapeutic effects. The therapeutic effect of ECT results from the induction of a generalized seizure. Most patients including schizophrenics undergoing ECT take concomitant psychotropic drugs, but little information is available on how these drugs affect ST. Our study aimed to analyze the relationship between ST and psychotropic drugs in patients treated with ECT. Patients with a history of seizure disorders or other medical emergent conditions were excluded. A total of fifty-eight subjects received ECT during the study period. Patients were excluded if treatment was aborted due to side effects or any other reasons before the 10th session (n=12) because we intended to investigate the ST shift during the course of consecutive ECT sessions. ECT was administrated with concurrent antipsychotics and antidepressants.67.4 percent of subjects were diagnosed as schizophrenia and 20.9 percent of subjects were diagnosed as major depressive disorder. We used chlorpromazine-equivalent dose for antipsychotics and fluoxetine-equivalent dose for antidepressants

Methods
Findings
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call